Bipradeb Singha

Title: Innovations in Cancer Treatment by Bipradeb Singha

Introduction

Bipradeb Singha is an accomplished inventor based in Philadelphia, PA. He has made significant contributions to the field of cancer treatment, particularly in developing methods for treating solid tumor cancers. His innovative approach focuses on utilizing a combination of specific inhibitors to enhance therapeutic outcomes for patients.

Latest Patents

Bipradeb Singha holds a patent for "Methods for treating solid tumor cancers using a histone deacetylase inhibitor and an IκB kinase inhibitor." This patent outlines a method for treating solid tumor cancers, specifically targeting ovarian cancer and drug-resistant solid tumors. The method involves administering a combination therapy that includes a therapeutically effective amount of an HDAC inhibitor and an IKK inhibitor to a subject in need. Additionally, the patent includes pharmaceutical compositions and kits that comprise these inhibitors.

Career Highlights

Bipradeb Singha is associated with St. John's University, where he continues to advance his research in cancer therapies. His work is characterized by a commitment to improving treatment options for patients suffering from challenging forms of cancer.

Collaborations

Some of his notable coworkers include Ivana Vancurova and Himavanth R Gatla, who contribute to the collaborative efforts in research and development within the field of oncology.

Conclusion

Bipradeb Singha's innovative work in cancer treatment exemplifies the potential of combining targeted therapies to improve patient outcomes. His contributions are paving the way for advancements in the fight against solid tumor cancers.